China CEA Carcinoembryonic Antigen Lateral Flow Test Kit

Product Main Parameters

Common Product Specifications

Product Manufacturing Process

The CEA lateral flow test is manufactured through a precise immunochromatographic process. The antibodies are immobilized on a nitrocellulose membrane, ensuring high sensitivity and specificity. These membranes are then assembled into test cassettes under strict quality controls, ensuring reliability and consistency. According to authoritative journals, this process ensures efficient binding of the target analyte, providing rapid results crucial for clinical environments.

Product Application Scenarios

CEA lateral flow tests are widely utilized in clinical diagnostics for detecting and monitoring carcinomas, particularly those of the pulmonary or gastrointestinal origin. Literature shows that these tests are essential for pre-treatment assessments, monitoring therapeutic responses, and early detection of cancer recurrence. Their rapid and reliable results make them suitable for use in hospitals, clinics, and even field settings where immediate diagnostic feedback is required.

Product After-Sales Service

We provide comprehensive after-sales support including technical assistance, replacement of defective kits, and customer service accessible via multiple channels.

Product Transportation

Products are shipped globally from our facility in China under controlled temperature conditions to maintain test integrity. Our logistics partners ensure timely and safe delivery.

Product Advantages

• Fast Results: Results in minutes
• High Sensitivity and Specificity
• Ease of Use: No specialized training required
• Portability and Convenience
• Cost-effective diagnostic solution

Product FAQ

1. What is the minimum detection level?

The minimum detection level is 5 ng/ml.

2. Can this test be used for self-testing?

No, the CEA lateral flow test is intended for professional use only.

3. What is the storage condition for the test kit?

Store the kit at room temperature or refrigerated (2-30°C). Do not freeze.

4. How long is the test kit valid?

The test is stable until the expiration date printed on the sealed pouch.

5. Can this test detect other antigens?

No, it is specific for Carcinoembryonic Antigen (CEA).

6. Is it necessary to use the entire kit at once?

No, individual test cassettes can be used separately as needed.

7. What sample types can be used?

The test can be performed using whole blood, serum, or plasma.

8. How should invalid results be interpreted?

If no control line appears, the test is invalid and should be repeated with a new cassette.

9. What should be done if the test shows positive?

Consult a medical professional for further diagnostic and therapeutic measures.

10. Are there any known interferences?

High concentrations of certain substances in the sample may interfere with the test results.

Product Hot Topics

1. Importance of early cancer detection using CEA tests in China

Early detection of cancer significantly improves treatment outcomes. The CEA lateral flow test, manufactured in China, enables rapid and reliable detection of elevated CEA levels, a crucial tumor marker. Its application in early diagnosis and monitoring recurrence has proven to be invaluable as supported by numerous clinical studies.

2. Reliability of China-manufactured lateral flow tests for cancer diagnostics

China has emerged as a leading manufacturer of high-quality lateral flow tests, including the CEA test. These tests undergo stringent quality control measures to ensure accuracy and reliability, providing healthcare professionals with dependable diagnostic tools for cancer detection and management.

3. Comparing lateral flow tests to other diagnostic methods in China

While PCR and ELISA tests offer high sensitivity and specificity, lateral flow tests provide rapid results and are more user-friendly. In China, the integration of lateral flow tests in clinical practice has enhanced the diagnostic capabilities, especially in resource-limited settings.

4. Storage and stability of lateral flow tests made in China

Lateral flow tests, including those manufactured in China, are designed to be stable under a wide range of storage conditions (2-30°C). Proper storage ensures the test's efficacy and reliability up to the expiration date, as documented by quality standards.

5. Advances in immunochromatography techniques in China

China has made significant advancements in immunochromatography, the technology behind lateral flow tests. Enhanced sensitivity, specificity, and user-friendliness of these tests, including the CEA test, have been achieved through continuous innovation and research.

6. Application of lateral flow tests in point-of-care settings in China

The portability and ease of use of lateral flow tests make them ideal for point-of-care settings. In China, these tests are increasingly used in clinics and remote areas, providing crucial diagnostic information swiftly and conveniently.

7. Cost-effectiveness of China-made lateral flow tests

Lateral flow tests produced in China offer a cost-effective alternative to traditional diagnostic methods. Their affordability, combined with reliability, makes them accessible to a broader population, facilitating early detection and better healthcare outcomes.

8. User experiences with China CEA lateral flow tests

Users have reported high satisfaction with the China CEA lateral flow tests due to their quick turnaround time, ease of use, and reliable results. Testimonials highlight their role in effective cancer monitoring and follow-up care.

9. Future of rapid diagnostics with lateral flow tests in China

The future of rapid diagnostics in China is promising with the continuous development of lateral flow tests. Innovations aim to enhance sensitivity, incorporate digital readouts, and expand the range of detectable analytes, further solidifying their role in modern healthcare.

10. Integration of lateral flow tests in China's healthcare system

The integration of lateral flow tests within China's healthcare system has streamlined diagnostic processes, reduced waiting times, and improved patient management. Their widespread adoption underscores their significance in the current and future landscape of medical diagnostics.